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Abstract
It has been postulated that bacteria attached to the surface of
prosthetic hip joints can cause localised inflammation, resulting
in failure of the replacement joint. However, diagnosis of
infection is difficult with traditional microbiological culture
methods, and evidence exists that highly fastidious or non-
cultivable organisms have a role in implant infections. The
purpose of this study was to use culture and culture-
independent methods to detect the bacteria present on the
surface of prosthetic hip joints removed during revision
arthroplasties. Ten consecutive revisions were performed by
two surgeons, which were all clinically and radiologically loose.
Five of the hip replacement revision surgeries were performed
because of clinical infections and five because of aseptic
loosening. Preoperative and perioperative specimens were
obtained from each patient and subjected to routine
microbiological culture. The prostheses removed from each
patient were subjected to mild ultrasonication to dislodge
adherent bacteria, followed by aerobic and anaerobic
microbiological culture. Bacterial DNA was extracted from each
sonicate and the 16S rRNA gene was amplified with the
universal primer pair 27f/1387r. All 10 specimens were positive
for the presence of bacteria by both culture and PCR. PCR
products were then cloned, organised into groups by RFLP
analysis and one clone from each group was sequenced.
Bacteria were identified by comparison of the 16S rRNA gene
sequences obtained with those deposited in public access
sequence databases. A total of 512 clones were analysed by
RFLP analysis, of which 118 were sequenced. Culture methods
identified species from the genera Leifsonia  (54.3%),
Staphylococcus  (21.7%),  Proteus  (8.7%),  Brevundimonas
(6.5%),  Salibacillus  (4.3%),  Methylobacterium  (2.2%) and
Zimmermannella  (2.2%). Molecular detection methods
identified a more diverse microflora. The predominant genus
detected was Lysobacter, representing 312 (60.9%) of 512
clones analysed. In all, 28 phylotypes were identified:
Lysobacter enzymogenes was the most abundant phylotype
(31.4%), followed by Lysobacter  sp. C3 (28.3%), gamma
proteobacterium N4-7 (6.6%), Methylobacterium SM4 (4.7%)
and  Staphylococcus epidermidis (4.7%); 36 clones (7.0%)
represented uncultivable phylotypes. We conclude that a
diverse range of bacterial species are found within biofilms on
the surface of clinically infected and non-infected prosthetic hip
joints removed during revision arthroplasties.
Introduction
Prosthetic joints are a major advance in the practice of modern
medicine and have revolutionised the life of many patients. At
least 50,000 total hip replacements are performed each year
in the UK [1]. The incidence of hip replacements worldwide is
expected to increase from 1.66 million in 1990 to 6.26 million
in 2050 and, in the European Union, an increase from 414,000
to 972,000 cases per annum is expected over the next 50
years [2]. Unfortunately the risk of infection is a significant
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problem, resulting in high rates of morbidity and creating a
massive economic burden.
Prosthetic joint infections of total hip arthroplasties (THAs)
reportedly occur with an incidence of 1.5% for the primary
THA and 3.2% for the revision THA [3]. However, one group
demonstrated that up to 15% of hip replacements in their
study were infected [4]. Several of these infections are char-
acterised by biofilms, adherent communities of bacteria
attached to the prosthetic hip joint components that are resist-
ant to antibiotic challenge and host immunity [5].
One of the major problems in accurately determining the infec-
tion rate is the difficulty in isolating, by traditional culture meth-
ods, the bacteria from the surface of the prosthetic hip joint
[6]. The reasons for this include strongly adherent bacteria in
the biofilm and the presence of antibiotic-containing cement.
One method developed to improve the microbial yield was to
place the hip prosthesis directly into an anaerobic jar after sur-
gical removal, followed by mild ultrasonication of the prosthe-
sis to remove adherent microbes and processing of the
specimens within an anaerobic cabinet [7]. Another reason for
the low yield of microbial growth may be that the joint is
infected with highly fastidious and non-cultivable, or viable but
non-cultivable, bacteria that cannot be isolated with standard
techniques. This problem can be overcome by the use of
molecular techniques to detect the microbial DNA from bacte-
ria present on the prosthesis. All culture-independent, molec-
ular-based studies that have investigated the microflora in a
wide range of environmental and clinical samples have identi-
fied a greater diversity of bacteria than culture methods alone
[8,9]. More specifically, this was found to be true in one study
that identified bacteria associated with failed prosthetic hip
joints [10]. Using PCR, these workers detected bacteria in
72% of the prosthetic hip joints removed during revision
arthroplasty, whereas there was only a 22% detection rate by
conventional culture. In addition, these workers were able to
reveal bacteria directly by immunofluorescence confocal
microscopy of sonicates from previously uncultured speci-
mens. Overall, this indicated that the incidence of prosthetic
hip joint infection is grossly underestimated by conventional
culture methods.
The purpose of this study was to identify bacteria within the
biofilms on the surface of clinically infected and non-infected
prosthetic hip joints by using both 16S rRNA-based molecular
detection methods and conventional microbiological culture.
Ten prosthetic hip joints were analysed for the presence of
bacteria by PCR amplification, cloning, and sequence analysis
of bacterial 16S rRNA genes. The results obtained were com-
pared with data obtained from aerobic and anaerobic micro-
biological culture of the same samples. The clinical interest of
this study is the presence of any organism on the prosthetic
hip joints and the role, if any, that they have in initiating, pro-
longing or activating simultaneous or subsequent clinical
infections.
Materials and methods
Selection of patients
Patients undergoing prosthetic hip joint revisions were
recruited from those attending the Department of Orthopaedic
Surgery at the Southern General Hospital, Glasgow. Each
patient gave written informed consent to participate in the
study. Ethical approval was obtained from the Ethics Commit-
tee of the Southern General Hospital, Glasgow.
Clinical samples and clinical data
Prosthetic hip joints were collected by a surgical team wearing
body exhaust suits in an operating theatre with a clean-air
enclosure. Ten prosthetic hip joint implants were retrieved by
two different surgeons from patients undergoing revision hip
surgery at the Southern General Hospital, Glasgow, during a
4-month period. Demographic and clinical data for the 10
patients are shown in Table 1. All 10 cases were clinically and
radiologically loose, with a varying risk of infection shown by
the raised levels of the infection markers C-reactive protein
and erythrocyte sedimentation rate. Taken together with post-
operative progress and results of conventional bacteriology,
this suggested that five prosthetic hip joint implants were
removed as a result of clinical infection and five as a result of
aseptic loosening of the prosthesis. On removal, the femoral
and acetabular cup components of the prosthetic hip joint
were placed into sterile plastic bags and immediately trans-
ported to Glasgow Dental Hospital and School for analysis.
Several preoperative and perioperative samples were also
taken from each patient, including hip joint aspirate, capsular
fluid, acetabular membrane, femoral membrane and (in certain
cases) pus, which were sent to the bacteriology laboratory at
the Southern General Hospital, Glasgow, for analysis. During
these revision operations no prophylactic antibiotics were
administered until the bacteriology samples had been
obtained and the prosthesis had been removed. The antibiotic-
loaded cement used at each primary revision was cefuroxime
with gentamicin.
Processing of preoperative and perioperative samples
With some minor amendments, preoperative and perioperative
samples were processed as described previously [6]. In brief,
samples were disrupted by vigorous agitation with sterile glass
beads in sterile diluent. Aliquots of the tissue suspension were
inoculated onto blood agar and chocolate blood agar plates
for incubation in a CO2 incubator and onto fastidious anaerobe
agar (FAA) containing blood for anaerobic incubation. Gram
staining was performed with a portion of the sample, and the
rest of the sample was inoculated into fastidious anaerobe
broth. Plates were examined daily for 7 days and the broths
were subcultured at 5 days, or sooner if turbid.Available online http://arthritis-research.com/content/9/3/R46
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Processing of prosthetic hip joint components
The femoral and acetabular components of the prosthetic hip
joint were processed separately to remove adherent bacteria.
The removal of bacteria from the hip joint components was
performed with a Fisherbrand FB11021 sonicating water bath
(Fisher Scientific, Loughborough, UK) in a class II microbio-
logical safety cabinet. All equipment including the water bath,
plasticware, pipettes and plastic bags were sterilised by ultra-
violet irradiation. Each hip joint component was sealed in a
sterile plastic bag to which 40 or 20 ml of sterile water was
added for the femoral component or acetabular cup compo-
nent, respectively. The sealed bags were then put into the son-
icating water bath for 5 minutes at 350 Hz. This process has
previously been shown not to affect bacterial viability nega-
tively [10]. Sonicate (10 ml) from each component was pooled
and subjected to microbiological culture as described below.
The remaining volume of sonicate for each prosthetic hip com-
ponent was then transferred to a sterile tube and centrifuged
at 1,000 g for 20 minutes. The supernatant was discarded and
the bacterial pellet was resuspended in 0.5 ml of sterile water,
pooled for each component and stored at – 80°C until
required for molecular analysis.
Microbiological culture
Each sonicate was centrifuged for 5 minutes at 2,500 r.p.m.;
the pellet was suspended in 1 ml of phosphate-buffered saline
and 10-fold serial dilutions to 10-6 were prepared. All dilutions
(from undiluted to 10-6) were spiral plated onto both Columbia
agar containing 7.5% (v/v) defibrinated horse blood and FAA
(BioConnections, Wetherby, UK) containing 7.5% (v/v) defi-
brinated horse blood. Dilutions (from undiluted to 10-3) were
also spiral plated onto skimmed milk agar, nutrient agar and
CY-agar plates. Columbia blood agar plates were incubated in
5% CO2 at 37°C, and FAA plates were incubated at 37°C in
an anaerobic chamber with an atmosphere of 85% N2, 10%
CO2 and 5% H2. Skimmed milk agar, nutrient agar and CY-
agar plates were incubated in 5% CO2 at 30°C. Plates were
examined after 1, 3 and 7 days, and morphologically distinct
colonies were subcultured to obtain pure cultures. Isolates
were identified by 16S rRNA gene sequencing as described
below.
DNA extraction
A crude DNA lysate of bacterial DNA from the prosthesis son-
icate was prepared. Samples were mechanically disrupted
with 1.0 mm glass beads (Thistle Scientific Ltd., Glasgow, UK)
and a Mini-BeadBeater (Stratech Scientific, Newmarket, UK).
These were homogenised three times for 30 seconds at 48
Hz, with cooling on ice between homogenisations. An aliquot
of the homogenate was then used for DNA extraction. To 100
μl of homogenate was added 3 μl of achromopeptidase (20 U/
μl in 10 mM Tris-HCl, 1 mM EDTA, pH 7.0), followed by incu-
bation at 56°C for 1 hour. Samples were boiled for 10 minutes,
debris was removed by centrifugation and the supernatant
was retained for PCR analysis. DNA was stored at – 20°C until
required. DNA was extracted from bacterial isolates by the
same method.
Polymerase chain reaction (PCR)
The primers used for amplification targeted conserved regions
of the 16S rRNA gene and were designed to amplify DNA
from most bacterial species. The primers used were 5' -AGA
GTT TGA TCM TGG CTC AG-3' (27f; Escherichia coli nucle-
otides 8–27) and 5' -GGG CGG WGT GTA CAA GGC-3'
(1387r; E. coli nucleotides 1,387-1,404; MWG Biotech, Mil-
ton Keynes, UK), where M = C or A and W = A or T, and give
an expected amplification product of about 1,400 base pairs
[11]. All PCR reactions were conducted in a total volume of 50
Table 1
Clinical details of the 10 patients studied
Patient no. Sex Age CRP (mg/l) ESR (mm/h) Hb (g/l) WCC (× 109 g/l) Clinical diagnosis Bacteriology results Duration prosthesis in 
place (months)
1 M 73 < 5 10 117 6.1 Aseptic loosening No growth 178
2 M 69 < 3 ND 150 6.5 Aseptic loosening No growth 48
3 M 61 61 49 130 10.6 Infected Coagulase-negative 
Staphylococcus (CF, AM, FM)
5
4 F 56 36 ND 134 6.9 Aseptic loosening No growth 79
5 M 65 36 14 142 6.7 Infected No growth 55
6 F 66 < 10 14 148 7.7 Infected Coagulase-negative 
Staphylococcus (CF, AM, FM)
n.d.
7 F 49 45 60 120 8.8 Infected Proteus mirabilis (AM, FM) n.d.
8 M 59 80 30 169 4.2 Aseptic loosening No growth 120
9 M 62 ND ND 119 3.9 Aseptic loosening No growth n.d.
10 M 57 131 ND 106 10.7 Infected No growth n.d.
CRP, C-reactive protein (reference range 0 to 6 mg/l); ESR, erythrocyte sedimentation rate (reference range 1 to 13 mm/h (male), 1 to 20 mm/h (female)); Hb, 
haemoglobin (reference range 130 to 170 g/l (male), 120 to 150 g/l (female)); WCC, white cell count (reference range 4.0 to 10.0 ng/l); AM, acetabular membrane; 
CF, capsular fluid; n.d., not determined; FM, femoral membrane.Arthritis Research & Therapy    Vol 9 No 3    Dempsey et al.
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μl, comprising 5 μl of extracted bacterial DNA and 45 μl of
reaction mixture containing 1 × PCR buffer (10 mM Tris-HCl
pH 9.0, 50 mM KCl, 1.5 mM MgCl2, 0.1% Triton X-100), 1.0
U Taq DNA polymerase (Promega, Southampton, UK), 0.2 mM
dNTPs (GE Healthcare, Little Chalfont, UK) and each primer
at a concentration of 0.2 μM. PCR was performed in an Omni-
Gene thermal cycler (Hybaid, Teddington, UK). The PCR
cycling conditions comprised an initial denaturation step at
94°C for 5 minutes, followed by 35 cycles of denaturation at
94°C for 1 minute, annealing at 58°C for 1 minute and exten-
sion at 72°C for 1.5 minutes, and finally an extension step at
72°C for 10 minutes.
PCR quality control
When performing PCR, stringent procedures were employed
to prevent contamination, as described previously [12]. Nega-
tive and positive controls were included with each batch of
samples being analysed. The positive control comprised a
standard PCR reaction mixture containing 10 ng of E. coli
genomic DNA instead of sample; the negative control con-
tained sterile water instead of sample. Each PCR product (10
μl) was subjected to electrophoresis on a 2% agarose gel, and
amplified DNA was detected by staining with ethidium bro-
mide (0.5 μg/ml) and examination under ultraviolet illumination.
Cloning of 16S rRNA PCR products
PCR products were cloned into pGEM-T Easy cloning vector
by using the pGEM-T Easy Vector System I Kit (Promega), in
accordance with the manufacturer's instructions.
PCR amplification of 16S rRNA gene inserts
After cloning of the 16S rRNA gene products amplified by
PCR for each sample, 50 clones from each generated library
were randomly selected. The 16S rRNA gene insert from each
clone was amplified by PCR with the use of the primer pair 5'
-GCT ATT ACG CCA GCT GGC GAA AGG GGG ATG TG-
3' (M13FAP) and 5' -CCC CAG GCT TTA CAC TTT ATG
CTT CCG GCA CG-3' (M13RAP). The M13FAP binding site
is located 32 base pairs upstream of the M13 forward primer
binding site, and the M13RAP binding site is located 39 base
pairs downstream of the M13 reverse primer binding site, in
the pGEM-T Easy vector.
Restriction enzyme analysis
Selected clones from the libraries generated from the 10 pros-
thetic hip samples were subjected to restriction enzyme anal-
ysis with RsaI and MnlI. About 0.5 μg of each PCR product
was digested at 37°C in a total volume of 15 μl with 2.0 U of
MnlI (Helena Biosciences, Sunderland, UK) or 2.0 U of RsaI
(Promega) for 3 hours. Restriction fragments were detected
by agarose gel electrophoresis as described above. For each
library, clones were initially sorted into distinct restriction frag-
ment length polymorphism (RFLP) groups on the basis of
restriction profiles obtained with RsaI. Further discrimination
was obtained by digestion of clones with MnlI, a restriction
enzyme that is highly effective at generating unique bacterial
16S rRNA fingerprints. This resulted in the identification of
additional distinct RFLP groups.
DNA sequencing
The 16S rRNA gene of a single, representative clone from
each RFLP group identified by restriction enzyme analysis was
sequenced. The resultant PCR products from the recombinant
clones were purified with the QIAquick PCR Purification Kit
(QIAGEN, Crawley, UK) in accordance with the manufac-
turer's instructions. Sequencing reactions were performed
with the Fermentas Life Sciences CycleReader™ Auto DNA
Sequencing Kit (Helena Biosciences) and IRD800-labelled
M13 universal (- 21); (5' -TGT AAA ACG ACG GCC ACT-3')
or 16S rRNA 357F (5' -CTC CTA CGG GAG GCA GCA G-
3') primer on a Primus96 DNA thermal cycler (MWG Biotech,
Milton Keynes, UK) with the use of the following cycling
parameters: an initial denaturation step at 92°C for 2 minutes,
followed by 30 cycles of denaturation at 94°C for 30 seconds,
annealing at 52°C for 30 seconds and extension at 72°C for 1
minute. Direct sequencing of bacterial isolates was performed
with the IRD800-labelled 357F primer, whereas sequencing of
recombinant clones was carried out with IRD800-labelled
M13 universal (- 21) primer. Formamide loading dye (6 μl) was
added to each reaction mixture after thermal cycling. Each
denatured sequencing reaction mixture (1.5 μl) was run on a
LI-COR Gene ReadIR 4200S automated DNA sequencing
system (LI-COR Biosciences UK Ltd, Cambridge, UK) in
accordance with the manufacturer's instructions.
16S rRNA gene sequence analysis
Sequence data were compiled with LI-COR Base ImagIR 4.0
software, converted to FASTA format and compared with 16S
rRNA gene sequences from public sequence databases
(GenBank and EMBL) using the advanced gapped BLAST
program, version 2.1 [13]. Clone sequences possessing at
least 98% identity with a sequence in the GenBank/EMBL
databases were considered to be that species.
Results
Culture-dependent methods
Bacteriology results for the preoperative and perioperative
samples (hip joint aspirate, capsular fluid, acetabular mem-
brane, femoral membrane and, in certain cases, pus) taken
from each of the 10 patients are shown in Table 1. Bacteria
were identified in at least one of these samples in only 3 of the
10 patients. Coagulase-negative Staphylococcus was identi-
fied in the capsular fluid, acetabular and femoral membranes
of two different cases (patients 3 and 6). Proteus mirabilis was
identified in the acetabular and femoral membranes of patient
7. The three cases from which bacteria were identified were all
clinically infected. No bacterial growth was observed for the
other seven cases analysed.Available online http://arthritis-research.com/content/9/3/R46
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Bacteria were isolated from all five clinically infected and five
clinically non-infected prosthetic hip joints. From the 10 pros-
thetic hip joints analysed, a total of 46 bacterial isolates were
obtained and identified by 16S rRNA gene sequencing.
Table 2 shows the isolates obtained from the 10 prosthetic hip
joints by culture and identified by 16S rRNA gene sequencing;
they are grouped according to genera. Species belonging to
the genus Leifsonia were the most prevalent, accounting for
over half of the isolates analysed. Other less predominant gen-
era included Staphylococcus (21.7%) and Proteus (8.7%).
The bacterial isolates obtained and identified by 16S rRNA
gene sequencing are categorised to species level in Table 3.
The most prevalent species was Leifsonia aquatica (43.5%),
followed by Staphylococcus epidermidis (19.6%) and Leifso-
nia shinshuensis (10.9%).
Culture-independent methods
A total of 512 clones from the five clinically infected and the
five clinically non-infected prosthetic hip joints were subjected
to restriction enzyme analysis. Because many RFLP groups
contained multiple clones with the same restriction profiles, a
single representative clone from each group was sequenced.
A DNA sequence of at least 500 base pairs was obtained for
each clone. In all, 118 clones were sequenced.
The bacterial genera/groups identified across the 10 samples
are shown in Table 4. Lysobacter  was the most prevalent
genus, accounting for over 60% of the clones analysed. Other
bacterial genera/groups identified included gamma proteo-
bacterium (8.0%), Stenotrophomonas (6.6%), Methylobacte-
rium  (4.7%) and Staphylococcus  (4.7%). The bacterial
species identified in the 10 samples are shown in Table 5. Lys-
obacter enzymogenes was the most prevalent species
(31.4% of analysed clones), followed by Lysobacter sp. C3
(28.3%), gamma proteobacterium (6.6%), Methylobacterium
SM4 (4.7%) and Staphylococcus epidermidis (4.7%). A total
of 28 phylotypes were identified.
Thirty-six (7.0%) analysed clones represented 10 different
uncultured phylotypes (Table 6). The most prevalent phylotype
was uncultured bacterium clone mw5, representing 19 (3.7%)
of the clones analysed. No potentially novel species
(sequence identities less than 98%) were identified.
Discussion
The risk of infection after hip replacement surgery remains
unacceptably high. A greater understanding of which microor-
ganisms may be involved in the infective process will be nec-
essary for an improvement in infection rates and subsequently
an improvement in treatment methods. In addition to the uncer-
tainty over the true prevalence of prosthetic hip joint infection,
in many cases there is also debate over the source of the infec-
tion. The skin microbiota of hospital staff or patients has been
assumed to be a likely reservoir of infection. For some patients
it has been demonstrated that the oral cavity is the source of
prosthetic joint infection [14-17]. However, there is continuing
debate over the need for antibiotic prophylaxis when patients
with joint prostheses undergo dental treatment procedures
that stimulate a bacteraemia [18].
Previous studies have shown that PCR amplification of the
16S rRNA gene, a highly conserved region within the bacterial
genome, is invaluable in the detection of the bacterial types
involved in prosthetic hip joint infections [10,19,20]. However,
it has been claimed that PCR assays cannot be used to iden-
tify each pathogen in cases of mixed infection [21] and have-
poor positive predictive value for hip joint infection [22].
However, we have shown in the present study that gene ampli-
fication and sequencing of 16S rRNA is useful in identifying
single bacterial species isolated by standard culture tech-
niques as well as in defining the mixed bacterial flora found on
the surface of the prosthetic hip joints by using a direct PCR
and sequencing approach. It is important to note that the nec-
essary precautions were taken to avoid contamination in the
Table 2
Bacterial genera identified by 16S rRNA gene sequencing of 
isolates from 10 prosthetic hip joints
Genus Number of isolates (percentage)
Leifsonia 25 (54.3)
Staphylococcus 10 (21.7)
Proteus 4 (8.7)
Brevundimonas 3 (6.5)
Salibacillus 2 (4.3)
Methylobacterium 1 (2.2)
Zimmermannella 1 (2.2)
The total number of samples was 46.
Table 3
Bacterial species identified by 16S rRNA gene sequencing of 
isolates from 10 prosthetic hip joints
Species Number of isolates (percentage)
Leifsonia aquatica 20 (43.5)
Staphylococcus epidermidis 9 (19.6)
Leifsonia shinshuensis 5 (10.9)
Proteus mirabilis 4 (8.7)
Brevundimonas sp. V4.BO.05 3 (6.5)
Salibacillus sp. YIM-kkny 16 2 (4.3)
Methylobacterium radiotolerans 1 (2.2)
Staphylococcus pasteuri 1 (2.2)
Zimmermannella alba 1 (2.2)
The total number of samples was 46.Arthritis Research & Therapy    Vol 9 No 3    Dempsey et al.
Page 6 of 11
(page number not for citation purposes)
clinical and laboratory settings. The prosthetic hip samples
were collected by a surgical team wearing body exhaust suits
in an operating theatre with a clean-air enclosure and were
packaged in sterile bags. In addition, PCR was performed
under stringent conditions and with the use of appropriate
controls to prevent false-positive results. Processing of the
prosthetic hip joints and subsequent DNA extractions were
conducted in a separate laboratory from the PCR assays. All
of the reagents for PCR were also stored separately from the
positive DNA samples, with the reagents being aliquoted
before use to avoid contamination. Finally, a negative control
was included with each PCR assay to rule out possible con-
tamination by bacterial DNA. A sterile hip, autoclaved and
processed in an identical manner to the 10 test hip joint com-
ponents, yielded a negative PCR result.
Clinical diagnosis of the 10 cases studied identified five hip
replacement devices removed because of bacterial infection
and the other five because of aseptic loosening. Comparison
of the bacterial species identified in both clinical situations
showed a large number of species that may be involved in
infection. The microflora associated with each prosthetic hip
joint studied was very similar, irrespective of the clinical reason
for prosthesis removal. No specific bacterial species that can
be associated with clinical infection or aseptic loosening were
found. The bacterial species identified take the form of a bio-
film attached to the surface of the removed prosthesis in both
infected and non-infected cases. It may be that one organism
alone or several bacterial species have a role in initiating, pro-
longing or activating simultaneous or subsequent joint infec-
tions. They may also have a role in rendering the joint more
susceptible to clinical infections.
The predominant bacteria identified by culture-independent
methods from the surface of all the prosthetic hip joints (both
infected and non-infected cases) were Lysobacter enzymo-
genes and Lysobacter sp. C3. Other members of the Lyso-
bacter clade [23] identified were Lysobacter sp. IB-9374, iron-
oxidising lithotroph ES-1 and hydrothermal vent eubacterium,
in addition to the closely related species Stenotrophomonas
maltophilia. These species, which have not previously been
reported to be involved in prosthetic hip infection, were not
identified by standard culture techniques. The role of Lyso-
bacter-type species in prosthetic hip joint infections is
unknown and further research will be required to study the vir-
ulence factors involved in infection and the effects on the
human immune system. However, Lysobacter-type species
have been shown to be important pathogens in hospital-
acquired infections [24]. In fact, it has recently been demon-
strated that various Lysobacter-type species have the ability to
form biofilms readily on various substrates. These include
Stenotrophomonas maltophilia,  Xylella fastidiosa and  Xan-
thomonas axonopodis [25-27]. It is therefore perhaps unsur-
prising that these species were identified on the prostheses of
the patients in our study.
Table 4
Bacterial genera/groups identified by 16S rRNA gene sequencing of clones from 10 prosthetic hip joints
Genus Number of clones analysed (percentage) Number of clones sequenced (percentage)
Lysobacter 312 (60.9) 52 (44.1)
Gamma proteobacterium 41 (8.0) 8 (6.8)
Stenotrophomonas 34 (6.6) 9 (7.6)
Methylobacterium 24 (4.7) 5 (4.2)
Staphylococcus 24 (4.7) 5 (4.2)
Various bacterial clones 23 (4.5) 10 (8.5)
Proteus 18 (3.5) 5 (4.2)
Bradyrhizobium 11 (2.1) 4 (3.4)
Bacteroides 6 (1.2) 3 (2.5)
Hydrothermal vent eubacterium 6 (1.2) 6 (5.1)
Iron-oxidising lithotroph ES-1 5 (1.0) 5 (4.2)
Methylobacteriaceaea 4 (0.8) 2 (1.7)
Acidobacteria 1 (0.2) 1 (0.8)
Eubacterium 1 (0.2) 1 (0.8)
Endophytic bacterium 1 (0.2) 1 (0.8)
Xylella 1 (0.2) 1 (0.8)
In all, 512 clones were analysed, and 118 clones were sequenced.aFamily.Available online http://arthritis-research.com/content/9/3/R46
Page 7 of 11
(page number not for citation purposes)
S. maltophilia was first reported as an environmental species
but is now known to be an emerging hospital-acquired patho-
gen that, among others, has been isolated from gentamicin-
loaded polymethylmethacrylate beads in orthopaedic revision
surgery [28]. A previous report of a strain of this organism,
which was positively charged, demonstrated favourable adhe-
sion kinetics to surfaces such as glass and Teflon [29], and S.
maltophilia is now known to adhere avidly to medical implants
and catheters to form a biofilm [30]. Furthermore, the organ-
ism has been implicated in a range of human infections, includ-
ing septic arthritis in a patient with AIDS [31].
Sullivan and colleagues [23] described the evolutionary rela-
tionship between members of the Lysobacter  clade.  Lyso-
bacter  sp. strain C3 was initially identified as
Stenotrophomonas maltophilia [32]. S. maltophilia has been
identified by 16S rRNA gene sequencing as the predominant
species in advanced noma lesions [33] and has been isolated
from a case of acute necrotising gingivitis in an immunocom-
promised individual [34]. Whether Stenotrophomonas/Lyso-
bacter species are natural members of the oral flora or are
merely transient would require further study. However, a high
oral carriage of S. maltophilia in a Tibetan population has been
reported [35].
Table 5
Bacterial species identified by 16S rRNA gene sequencing of clones from 10 prosthetic hip joints
Species Number of clones analysed (percentage) Number of clones sequenced (percentage)
Lysobacter enzymogenes 161 (31.4) 27 (22.9)
Lysobacter sp. C3 145 (28.3) 24 (20.3)
Gamma proteobacterium N4-7 34 (6.6) 7 (5.9)
Methylobacterium SM4 24 (4.7) 5 (4.2)
Staphylococcus epidermidis 24 (4.7) 5 (4.2)
Uncultured bacterium clone mw5 19 (3.7) 6 (5.1)
Proteus mirabilis 18 (3.5) 5 (4.2)
Stenotrophomonas sp. SAFR-173 18 (3.5) 7 (5.9)
Stenotrophomonas maltophilia 16 (3.1) 2 (1.7)
Bradyrhizobium sp. BC-C1 8 (1.6) 1 (0.8)
Uncultured gamma proteobacterium clone B22B17 7 (1.4) 1 (0.8)
Bacteroides fragilis 6 (1.2) 3 (2.5)
Lysobacter sp. IB-9374 6 (1.2) 1 (0.8)
Hydrothermal vent eubacterium 6 (1.2) 6 (5.1)
Iron-oxidising lithotroph ES-1 5 (1.0) 5 (4.2)
Uncultured Methylobacteriaceae clone M3Ba28 2 (0.4) 1 (0.8)
Uncultured Methylobacteriaceae clone 10-3Ba12 2 (0.4) 1 (0.8)
Bradyrhizobium japonicum 1 (0.2) 1 (0.8)
Bradyrhizobium sp. CCBAU 1 (0.2) 1 (0.8)
Uncultured rape rhizosphere bacterium wr0008 1 (0.2) 1 (0.8)
Acidobacterium sp. TAA166 1 (0.2) 1 (0.8)
Endophytic bacterium 1 (0.2) 1 (0.8)
Xylella fastidiosa 1 (0.2) 1 (0.8)
Uncultured Eubacterium clone GL178.11 1 (0.2) 1 (0.8)
Uncultured bacterium Br-z43 1 (0.2) 1 (0.8)
Uncultured bacterium clone BA017 1 (0.2) 1 (0.8)
Uncultured bacterium clone LG25 1 (0.2) 1 (0.8)
Uncultured bacterium clone I-9 1 (0.2) 1 (0.8)
In all, 512 clones were analysed, and 118 clones were sequenced.Arthritis Research & Therapy    Vol 9 No 3    Dempsey et al.
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From the cultured bacterial isolates sequenced, nine different
species were identified that are thought to be involved in pros-
thetic hip joint infections; Staphylococcus species have previ-
ously been described in this context [7,20,22], but the other
bacteria identified are not commonly associated with pros-
thetic hip joint infections. Leifsonia  species are known to
favour moist environments, and in association with other bac-
terial species they cause infections of the central venous cath-
eter used as vascular access for haemodialysis [36]. Proteus
mirabilis has been described in joint infections [20] but is
more commonly associated with urinary tract infections [37].
Brevundimonas species are rarely isolated from clinical sam-
ples; the role of this species in human disease needs further
research, but it has been associated with two cases of blood-
stream infections [38]. Zimmermannella alba has been iso-
lated from human blood [39] but has not been reported to be
involved in prosthetic hip joint infections. Methylobacterium
radiotolerans [40] and Salibacillus species (GenEMBL acces-
sion number AY121439) are environmental bacteria more
commonly found in plants and salt water lakes, respectively.
A further 21 species of bacteria were identified by culture-
independent methods. As stated previously, Staphylococcus
and Proteus [7,20,22] species are associated with prosthetic
hip joint infections and were isolated by microbiological cul-
ture and culture-independent methods in the current study.
Several other species that differ from those identified by micro-
biological culture were identified by culture-independent
methods. Bacteroides fragilis has previously been associated
with hip joint infections and has been isolated in cases of sep-
tic arthritis [41]. Many of the other species identified have
been more commonly isolated from plants and soil; these
include gamma proteobacterium [23], Methylobacterium [42],
Bradyrhizobium [43], Acidobacteria [44] and Xyella [45]. For
example,  Xyella fastidiosa is a phytopathogenic bacterium
responsible for diseases in many economically important
crops [45]. The uncultivable species identified in the present
study are environmental bacteria [46,47]. Although these bac-
teria could not be cultured by standard microbiological tech-
niques in the present study, this might have been due to the
fastidious growth requirements of these organisms, or to the
fact that bacteria growing within a surface-associated biofilm
displayed viable but non-culturable tendencies. A recent
review has highlighted the plethora of clinical and environmen-
tal bacteria that have this characteristic, but whether they are
capable of pathogenic traits has yet to be determined [48]. In
addition, the use of prophylactic antibiotics during the surgical
procedure would hinder the ability to culture and isolate bac-
teria. However, in our current study none of the patients
received antibiotic prophylaxis before surgery.
It was interesting to note that the bacterial species found in the
preoperative/perioperative samples by culture (coagulase-
negative  Staphylococcus, patients 3 and 6; P. mirabilis,
patient 7) were also found on the surface of the corresponding
prosthetic hip joints by both culture and culture-independent
methods. This is suggestive of potential involvement of these
species in the infective process. Bacteria were cultured from
preoperative/perioperative samples in only 3 out of 10 cases
analysed, whereas all 10 corresponding prosthetic hip joints
were positive for the presence of bacteria by both culture and
culture-independent methods. Furthermore, bacteria were iso-
lated from preoperative/perioperative samples in only three of
the five cases classified as being clinically infected. This
clearly suggests that standard methods for determining infec-
tion in these cases are unreliable.
Several unusual bacterial species have been isolated during
this study that have not previously been described as human
pathogens and have not been implicated in human infections
of prosthetic hip joints. Most of the unusual species identified
are environmental bacteria isolated more commonly from
Table 6
Details of clones sequenced representing uncultured species
Sample no. (clone) Sequenced bases 
available for BLAST
Matching bases Sequence identity 
(percentage)
Accession no. Identified bacterial species
4 (32) 621 542/550 98.5 AF323759 Uncultured bacterial clone BA017
6 (21) 513 494/503 98.2 AY038628 Uncultured Eubacterium clone GL178.11
24 (32) 683 651/658 98.9 AJ295469 Uncultured rape rhizosphere bacterium wr0008
32 (24) 527 469/479 97.9 AY360534 Uncultured Methylobacteriaceae clone 10-3Ba12
32 (32) 654 626/632 99.1 AY625143 Uncultured bacterial clone I-9
34 (29) 570 535/543 98.5 AY539816 Uncultured gamma proteobacterium clone B22B17
42 (19) 733 722/731 98.8 AY360692 Uncultured Methylobacteriaceae clone M3Ba28
47 (21)a 510 467/477 97.9 DQ163946 Uncultured bacterium clone mw5
58 (24) 621 567/576 98.4 AF507008 Uncultured bacterium Br-z43
87 (28) 692 628/637 98.6 AY977912 Uncultured bacterium clone LG25
aSix clones possessed identical RFLP profiles.Available online http://arthritis-research.com/content/9/3/R46
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plants. Further research is required into the pathogenicity of
these bacterial species. It may be that they show pathogenic
potential only when they are part of a biofilm in association
with other bacterial species. This is indeed the case with Leif-
sonia species, which are reported to cause infections of the
central venous catheter when they are in a biofilm with two
other unusual bacterial species [36]. Furthermore, Duan and
colleagues [49] demonstrated that key virulence factors from
the biofilm-forming organism Pseudomonas aeruginosa were
upregulated in the presence of oropharyngeal commensal
flora. These studies indicate the key role of polymicrobial bio-
films in clinical biofilm diseases, and how cell-cell interactions
from non-pathogenic organisms may promote the progression
of disease.
There were differences in the bacterial species identified by
the microbiological culture and culture-independent methods
used in the current study. The species identified that were
common to both methods were from the genera Staphylococ-
cus and Proteus, which have previously been associated with
hip joint infections. One possible reason for this is the culture
techniques used: in this study we used standard culture media
and incubation conditions, which broadly enabled us to max-
imise the culture of bacteria. However, this approach may not
have been specific enough for other fastidious organisms.
Because the species present on the surface of the prosthetic
hip joints are unknown, it is not possible to use specialised
media and conditions at this stage, primarily because of cost
implications and the time required to process specimens on a
vast array of media. Now that it is known that Lysobacter-type
species are predominant in prosthetic hip joint infections it will
be possible to use specialised media to culture them from the
hip sonicate. This exemplifies the validity for culture-independ-
ent methods to be conducted in parallel with the culture tech-
niques, so as to identify the entire array of infecting bacteria in
each clinical sample.
Another reason for the differences observed may be that
primer bias occurs during the PCR procedure. Primer bias
results in the unequal amplification of PCR products, resulting
in distortion in the product numbers for each bacterial type.
PCR primer bias is thought to be caused by inhibition of ampli-
fication by self-annealing of the most abundant templates in
the late stages of amplification [50] or as a result of differ-
ences in the amplification efficiency of templates [51]. We
have shown that neither method on its own can isolate all bac-
teria involved in prosthetic hip joint infections. The vast major-
ity of the bacteria identified that had previously been
characterised were Gram-negative species, with the only
Gram-positive species being Staphylococcus epidermidis,
Staphylococcus pasteuri, Leifsonia aquatica, Leifsonia shin-
shuensis, Salibacillus sp. and Zimmermannella alba. Some
studies, which used 16S rRNA gene sequencing to identify
bacteria in a relatively small number of clinical specimens,
adopted the approach of sequencing about 50 clones from
each library generated per sample [33,52]. Because of the rel-
atively large number of samples analysed in our study we
sought to minimise the sequencing of identical clones by
screening with RFLP analysis, and sequencing a single repre-
sentative clone from each RFLP group. This approach has
been used successfully in many studies to avoid sequencing
redundancy and to estimate bacterial diversity within clinical
specimens [53-55].
From our findings it can be seen that a wide range of bacteria
are potentially associated with prosthetic hip joint infections.
Further research is required to identify other bacteria involved
in infections, because other species have been reported in the
literature that were not identified in this study. The knowledge
of the bacteria involved in infection can further our research
into biofilm formation, into the signalling patterns between the
bacteria within the biofilm and into the effects on the human
immune system of these infecting pathogens that lead to pros-
thetic hip joint infections. Although the immediate clinical sig-
nificance of the present study is somewhat limited, it
nonetheless represents a useful preliminary investigation into
the microbiology of the aseptic loosening and infection of
prosthetic hip joints. Ideally, the study should be expanded to
include a larger number of specimens to determine whether
true differences exist with regard to the microflora associated
with both groups. Because the present study detected only
microbial DNA, it is unknown which of the bacteria identified
were viable. This could be overcome in future studies by the
detection of bacterial mRNA rather than DNA, which would
identify only the transcriptionally active (viable) bacteria
present on infected and uninfected prosthetic hip joints. This
would give a greater insight into which species may be of clin-
ical significance. Ultimately, such data could inform both anti-
biotic usage in prosthetic joint surgery (both prophylactic and
therapeutic) and the relative merits of one-stage and two-
stage revisions. However, it should be noted that the antibiotic
susceptibility profiles of the bacterial species identified by cul-
ture-independent techniques cannot be determined, and this
may hinder the development of improved antimicrobial therapy
regimes. This study may also have a potential impact on
improving the laboratory diagnosis of prosthetic hip joint
infections.
Conclusion
A wide range of bacteria can be found on the surface of pros-
thetic hip joints removed at revision arthroplasty. No significant
differences were observed in the microflora associated with
infected and non-infected cases. However, the predominant
species were members of the Lysobacter genus.
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